-
Product Insights
Mylan Lab – Mylan Pharmaceutical Plant Development – Madhya Pradesh
Equip yourself with the essential tools needed to make informed and profitable decisions with our Mylan Lab - Mylan Pharmaceutical Plant Development - Madhya Pradesh report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Mylan Labs – Kurubarapalli Injection Manufacturing Plant – Tamil Nadu
Equip yourself with the essential tools needed to make informed and profitable decisions with our Mylan Labs - Kurubarapalli Injection Manufacturing Plant - Tamil Nadu report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
Net Present Value Model: Fampyra
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Fampyra Drug Details Dalfampridine (Ampyra, Fampyra,...
-
Product Insights
![]()
Net Present Value Model: Zovirax Franchise
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Zovirax Franchise Drug Details Acyclovir (Zovirax, Activir,...
-
Sector Analysis
Diabetic Macular Edema Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
The Diabetic Macular Edema market size was $5.05 billion in 2021 across the 7MM (seven major pharmaceutical markets). The market is forecast to achieve a CAGR of more than 8% during the forecast period. Diabetic Macular Edema is a complication of type 1 and 2 diabetes with diabetic retinopathy. It is a leading cause of visual impairment and blindness in first-world countries, affecting over 28 million people (International Diabetes Federation, 2016; de Moura et al., 2020). The DME research report...
-
Product Insights
Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Neutropenia is an abnormally low count of neutrophils, a type of white blood cell that helps fight off infections, particularly those caused by bacteria and fungi. Signs and symptoms include fevers, frequent infections, mouth ulcers, gum infections, and dysuria. Key Targets Granulocyte Colony Stimulating Factor Receptor, Beta Lactamase, C5a Anaphylatoxin Chemotactic Receptor 1, Caspase 3, Caspase 8, Caspase 9, Ergosterol, Lanosterol 14 Alpha Demethylase, Penicillin Binding Protein 1B, Penicillin Binding Protein 1C, Penicillin Binding Protein 3, Retinoic Acid Receptor Alpha,...
-
Product Insights
Gastric Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastric Ulcers Drugs in Development Report Overview A gastric ulcer is a painful sore or ulcer in the lining of the stomach. The most common cause of gastric ulcer is Helicobacter pylori bacterial infection. Symptoms include pain, bloating, retching, nausea or vomiting, and unexplained weight loss. Predisposing factors include smoking and alcoholism. Treatment includes antibiotics and antacids. The Gastric Ulcers pipeline drugs market research report provides comprehensive information on the therapeutics under development for Gastric Ulcers, complete with analysis by...
-
Product Insights
Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Injectable drug delivery devices are defined as the administration of a drug into a patient’s blood through a delivery device. The injectable drug delivery pipeline market research report provides comprehensive information about the injectable drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Cerebral Palsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The cerebral palsy pipeline market research report provides comprehensive information on the therapeutics under development for Cerebral Palsy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cerebral Palsy and features dormant...
-
Sector Analysis
Cystic Fibrosis – Global Drug Forecast and Market Analysis to 2030
The global (7MM) sales for the cystic fibrosis (CF) have been valued at $8.2 billion in 2020. The market is expected to grow at a CAGR of more than 4% during 2021-2025. Over the past decade, there have been significant changes in the CF market due to the development of CFTR modulator therapies that target the underlying cause of CF. Most of the sales has come from the US, which represents more than 75% of the market by 2030. The...
-
Sector Analysis
Human Immunodeficiency Virus (HIV) Therapeutics – Global Drug Forecast and Market Analysis to 2029
The human immunodeficiency virus (HIV) therapeutics market was worth an estimated $22.9bn across the seven major markets (7MM*) in 2019. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 2%. Growth in the market will be driven by the entry of injectable therapies that can be administered intramuscularly or subcutaneously. HIV-infected patients are normally managed with oral therapies. One type of treatment regimen involves the administration of one tablet per day. These single-tablet regimens (STRs)...
-
Sector Analysis
Supportive Care in Cancer – Comprehensive Overview, Pipeline Products, Research and Development Strategies and Unmet Needs
Supportive care in cancer is an evolving discipline of medicine that is critical for holistic management of patients with cancer. With significant advancements being made in treatment of cancer particularly through development of immuno-oncology (IO) and targeted therapies, it is of equal significance to focus on supportive care in cancer so as to ensure that patients are able to complete the treatment cycle for the primary cancer as well as to enhance their quality of life. The report leverages on...
-
Sector Analysis
Acromegaly and Gigantism – Global Drug Forecast and Market Analysis to 2029
Acromegaly and gigantism are rare disorders of the pituitary gland characterized by the hypersecretion of growth hormone (GH). This GH excess is often a result of a benign GH-secreting pituitary adenoma. Rarely, tumors in other organs can secrete growth hormone-releasing hormone (GHRH), leading to elevation in GH levels in the serum. This triggers the release of anti-apoptotic and mitogenic peptide hormone, insulin-like growth factor 1 (IGF-1). While both acromegaly and gigantism are complications of uncontrolled GH levels, the presentation of...
-
Product Insights
Liver Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Liver Cancer Diagnostic Tests include assays of mostly antibodies released in response to a liver cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Liver Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Liver Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
Parasitology and Mycology Tests – Medical Devices Pipeline Assessment, 2020
Parasitology & Mycology Tests comprises of test kits intended for diagnosis through immuno assays for the detection of pathogenic protozoans and fungi. GlobalData's Medical Devices sector report, “Parasitology & Mycology Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Parasitology & Mycology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Parasitology & Mycology Tests Pipeline Assessment report provides key information and data...
-
Product Insights
Ovarian Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Ovarian Cancer Diagnostic Tests include assays of mostly antibodies released in response to a ovarian cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Ovarian Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
Lung Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Lung Cancer Diagnostic Tests include assays of mostly antibodies released in response to a lung cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Lung Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Lung Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
Mania Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Mania Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Mania Clinical trials scenario. This report provides top line data relating to the clinical trials on Mania. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Alzheimer Diagnostic Tests are test that detects the disease before it causes the symptoms. It measures key proteins or protein patterns in blood or spinal fluid (biomarkers). GlobalData's Medical Devices sector report, “Alzheimer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Alzheimer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Alzheimer Diagnostic Tests Pipeline Assessment report provides key information...
-
Product Insights
Cystitis Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Cystitis Global Clinical Trials Review, H2, 2020" provides an overview of Cystitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Cystitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.